Enhanced counselling for women undergoing BRCA1/2 testing: Impact on knowledge and psychological distress-results from a randomised clinical trial

Psychology and Health

Volumn 25, Issue 4, 2010, Pages 401-415

  Roussi, Pagona ^a   Sherman, Kerry Anne ^b   Miller, Suzanne ^c   Buzaglo, Joanne ^c   Daly, Mary ^c   Taylor, Alan ^b   Ross, Eric ^c   Godwin, Andrew ^c  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b MACQUARIE UNIVERSITY   (Australia)

^c FOX CHASE CANCER CENTER   (United States)

Author keywords

Breast cancer; Enhanced counselling; Genetic testing; Intrusive ideation; Ovarian cancer

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ARTICLE; ATTITUDE TO HEALTH; BREAST TUMOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENETIC COUNSELING; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; HUMAN; METHODOLOGY; MIDDLE AGED; MUTATION; OVARY TUMOR; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL;

BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; FEMALE; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS;

EID: 77951189878     PISSN: 08870446     EISSN: 14768321     Source Type: Journal    
DOI: 10.1080/08870440802660884     Document Type: Article

References (41)

1. Bish, A., Sutton, S., Jacobs, C., Levene, S., & Ramirez, A. (2002). No news is (not necessarily) good news: Impact of preliminary results for BRCA1 mutation searches. Genetics in Medicine, 4, 353-358.
2. Borkovec, T.D., & Stoeber, J. (1998). Worry: A cognitive phenomenon intimately linked to affective, physiological and interpersonal behavioral processes. Cognitive Therapy and Research, 8, 561-576.
3. Braithwaite, D., Emery, J., Walter, F., Prevast, A.T., & Sutton, S. (2004). Psychological impact of genetic counseling for familial cancer: A systematic review and meta-analysis. Journal of the National Cancer Institute, 96(2), 122-133.
4. Claes, E., Evers-Kiebooms, G., Boogaerts, A., Decruyenaere, M., Denayer, L., & Legius, E. (2004). Diagnostic genetic testing for hereditary breast and ovarian cancer in cancer patients: Women's looking back on the pre-test period and a psychological evaluation. Genetic Testing, 8, 13-21.
5. Daly, M. (1999). NCCN practice guidelines: Genetics/familial high-risk cancer screening. Oncology, 13,161-183.
6. Diefenbach, M.A., Miller, S.M., Porter, M., Peters, E., Stefanek, M., & Leventhal, H. (2007). Affect and screening for cancer: A self-regulation perspective. In M. Lewis, & J.M. Haviland (Eds.), Handbook of emotions (pp. 645-660). New York, NY: Guilford Press.
7. Green, M.J., Peterson, S.K., Baker, M.W., Harper, G.R., Friedman, L.C., Rubinstein, W.S., et al. (2004). Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility. Journal of the American Medical Association, 292, 442-452.
8. Hallowell, N., Foster, C., Ardern-Jones, A., Eeles, R., Murday, V., & Watson, M. (2002). Genetic testing for women previously diagnosed with breast/ovarian cancer: Examining the impact of BRCA1 and BRCA2 mutation searching. Genetic Testing, 6, 79-87.
9. Hamann, H.A., Somers, T.J., Smith, A.W., Inslicht, S.S., & Baum, A. (2005). Posttraumatic stress associated with cancer history and BRCA1/2 genetic testing. Psychosomatic Medicine, 67, 766-772.
10. Hopwood, P. (2005). Psychosocial aspects of risk communication and mutation testing in familial breast-ovarian cancer. Current Opinion in Oncology, 17, 340-344.
11. Horowitz, M., Wilner, N., & Alvarez, W. (1979). Impact of events scale: A measure of subjective stress. Psychosomatic Medicine, 41, 209-218.
12. Howell, D.C. (1997). Statistical methods of psychology (4th ed.). Belmont, CA: Wadsworth.
13. Lerman, C., Narod, S., Schulman, K., Hughes, C., Gomez-Caminero, A., Bonney, G., et al. (1996). BRCA1 testing in families with hereditary breast-ovarian cancer: A prospective study of patient-decision making and outcomes. Journal of the American Medical Association, 275, 1885-1892.
14. Lerman, C., Trock, B., Rimer, B.K., Jepson, C., Brody, D., & Boyce, A. (1991). Psychological side effects of breast cancer screening. Health Psychology, 10, 259-267.
15. Loader, S., Shields, C.G., & Rowley, P.T. (2004). Impact of genetic testing for breast-ovarian cancer susceptibility. Genetic Testing, 8, 1-12.
16. Meiser, B. (2005). Psychological impact of genetic testing for cancer susceptibility: An update of the literature. Psycho-oncology, 14, 1060-1074.
17. Meiser, B., Butow, P., Friedlander, M., Barratt, A., Schnieden, V., Watson, M., et al. (2002). Psychological impact of genetic testing in women from high-risk breast cancer families. European Journal of Cancer, 38, 2025-2031.
18. Meiser, B., & Halliday, J.L. (2002). What is the impact of genetic counselling in women at increased risk of developing hereditary breast cancer? A meta-analytic review. Social Science & Medicine, 54,1463-1470.
19. Miller, S.M. (1987). Monitoring and blunting: Validation of a questionnaire to assess styles of information seeking under threat. Journal of Personality and Social Psychology, 52, 345-353.
20. Miller, S.M. (1995). Monitoring versus blunting styles of coping with cancer influence the information patients want and need about their disease: Implications for cancer screening and management. Cancer, 76, 167-177.
21. Miller, S.M., Fleisher, L., Roussi, P., Buzaglo, J.S., Schnoll, R., Slater, E., et al. (2005a). Facilitating informed decision making about breast cancer risk and genetic counseling among women calling the NCI's cancer information service. Journal of Health Communication, 10, 119-136.
22. Miller, S.M., McDaniel, S., Rolland, J., & Feetham, S. (Eds.). (2006). Individuals, families and the new era of genetics: Biopsychosocial perspectives. New York: Norton Publications.
23. Miller, S.M., Roussi, P., Daly, M.B., Buzaglo, J.S., Sherman, K., Godwin, A.K., et al. (2005b). Enhanced counseling for women undergoing BRCA1/2 testing: Impact on subsequent decision making about risk reduction behaviors. Health Education and Behavior, 32, 654-667.
24. Miller, S.M., Shoda, Y., & Hurley, K. (1996). Applying cognitive-social theory to health protective behavior: Breast self-examination in cancer screening. Psychological Bulletin, 119, 70-94.
25. O'Connor, A.M., Legare, F., & Stacey, D. (2003). Risk communication in practice: The contribution of decision aids. British Medical Journal, 327, 736-740.
26. Randall, J., Butow, P., Kirk, J., & Tucker, K. (2001). Psychological impact of genetic counselling and testing in women previously diagnosed with breast cancer. Internal Medicine Journal, 31, 397-405.
27. Schwartz, M.D., Peshkin, B.N., Hughes, C., Main, D., Isaacs, C., & Lerman, C. (2002). Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample. Journal of Clinical Oncology, 20, 514-520.
28. Shoda, Y., Mischel, W., Miller, S., Diefenbach, M., Daly, M.B., & Engstrom, P.F. (1998). Psychological interventions and genetic testing: Facilitating informed decisions about BRCA1/2 cancer susceptibility. Journal of Clinical Psychology in Medical Settings, 5, 3-17.
29. Sinharay, S., Stern, H.S., & Russell, D. (2001). The use of multiple imputation for the analysis of missing data. Psychological Methods, 6, 317-329.
30. Skinner, C.S., Schildkraut, J.M., Berry, D., Calingaert, B., Marcom, P.K., Sugarman, J., et al. (2002). Pre-counseling education materials for BRCA testing: Does tailoring make a difference? Genetic Testing, 6, 93-105.
31. Spielberger, C.D., Gorsuch, R.L., & Lushene, R. (1983). State-trait anxiety inventory for adults: Sampler set manual, test, scoring key. Palo Alto, CA: Mind Garden.
32. van Buren, S., Boshuizen, H.C., & Knook, D.L. (1999). Multiple imputation of missing blood pressure covariates in survival analysis. Statistics in Medicine, 18, 681-694.
33. van Dijk, S., Timmermans, D.R.M., Meijers-Heijboer, H., Tibben, A., van Asperen, C.J., & Otten, W. (2006). Clinical characteristics affect the impact of an uninformative DNA test result: The course of worry and distress experienced by women who apply for genetic testing for breast cancer. Journal of Clinical Oncology, 24, 3672-3677.
34. van Roosmalen, M.S., Stalmeier, P.F.M., Verhoef, L.C.G., Hoekstra-Weebers, J.E.H.M., Oosterwijk, J.C., Hoogerbrugge, N., et al. (2004a). Randomised trial of decision aid and its timing for women being tested for a BRCA1/2 mutation. British Journal of Cancer, 90, 333-342.
35. van Roosmalen, M.S., Stalmeier, P.F.M., Verhoef, L.C.G., Hoekstra-Weebers, J.E.H.M., Oosterwijk, J.C., Hoogerbrugge, N., et al. (2004b). Randomised trial of a shared decision-making intervention consisting of trade-offs and individualized treatment information for BRCA1/2 mutation carriers. Journal of Clinical Oncology, 22, 3293-3301.
36. van Roosmalen, M.S., Stalmeier, P.F.M., Verhoef, L.C.G., Hoekstra-Weebers, J.E.H.M., Oosterwijk, J.C., Hoogerbrugge, N., et al. (2004c). Impact of BRCA1/2 testing and disclosure of a positive test result on women affected and unaffected with breast or ovarian cancer. American Journal of Medical Genetics, 124A, 346-355.
37. Wang, C.W., Gonzalez, R., & Merajver, S.D. (2004). Assessment of genetic testing and related counseling services: Current research and future directions. Social Science & Medicine, 58, 1427-1442.
38. Wang, C.W., Gonzalez, R., Milliron, K.J., Strecher, V.J., & Merajver, S.D. (2005). Genetic counselling for BRCA1/2: A randomized controlled trial of two strategies to facilitate the education and counseling process. American Journal of Medical Genetics, 134A, 66-73.
39. Watson, M., Foster, C., Eeles, R., Eccles, D., Ashley, S., Davidson, R., et al. (2004). Psychosocial impact of breast/ovarian (BRACA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort. British Journal of Cancer, 91, 1787-1794.
40. Williams-Piehota, P., Pizarro, J., Schneider, T.R., Mowad, L., & Salovey, P. (2005). Matching health messages to monitor-blunter coping styles to motivate screening mammography. Health Psychology, 24, 58-67.
41. Wood, M.E., Mullineaux, L., Rahm, A.K., Fairclough, D., & Wenzel, L. (2000). Impact of BRCA1 testing on women with cancer: A pilot study. Genetic Testing, 4, 265-272.